In an announcement, Teva Pharmaceuticals released the IMPACT-TD Scale, a clinician-rated tool designed to help health professionals gauge the effect of tardive dyskinesia (TD) on a patient’s daily life.
IMPACT-TD Scale Launched for Comprehensive Evaluation of Tardive Dyskinesia in Daily Life
POCNnews2023-08-30T00:24:08+00:00August 25th, 2023|Tardive Dyskinesia|Comments Off on IMPACT-TD Scale Launched for Comprehensive Evaluation of Tardive Dyskinesia in Daily Life
Related Posts
Antipsychotic-Induced Tardive Dyskinesia: What the Evidence Says About Vitamin E
February 12th, 2026